Immersive Virtual Reality, a powerful non-pharmacologic analgesic for pediatric patients, is at a turning point.  It is transitioning from Research only to everyday Clinical practice in hospitals.  Billions of dollars are being invested into research and development of virtual reality technology.  Mass production has dropped the price of a good VR helmet from $35,600 per helmet in 2013, to $400 per helmet in 2022.  The company named Meta has sold over 15 million Quest2 VR helmets in less than two years.  Hoffman will give a brief history of the evolution of VR analgesia in pediatric patients, from his first burn patients with Dave Patterson at Harborview Burn Center in the 1990s, to recent big breakthroughs by big tech that make VR usable, cost effective, and powerful.